Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Tharimmune ( (THAR) ) has issued an update.
On October 1, 2025, Tharimmune, Inc. amended its warrants agreement with holders to allow the immediate exercise of warrants for 3,408,110 shares of common stock. This strategic move could enhance liquidity and potentially strengthen the company’s financial position, impacting its market operations and stakeholders positively.
The most recent analyst rating on (THAR) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Tharimmune stock, see the THAR Stock Forecast page.
More about Tharimmune
Average Trading Volume: 9,986,232
Technical Sentiment Signal: Hold
Current Market Cap: $16.02M
For an in-depth examination of THAR stock, go to TipRanks’ Overview page.